Literature DB >> 12740278

Complications of intermittent prone positioning in pediatric patients receiving extracorporeal membrane oxygenation for respiratory failure.

Susan M Haefner1, Susan L Bratton, Gail M Annich, Robert H Bartlett, Joseph R Custer.   

Abstract

STUDY
OBJECTIVE: To describe the safety and risks of placing pediatric patients in the prone position during extracorporeal membrane oxygenation (ECMO) for the treatment of respiratory failure.
DESIGN: Single-center retrospective cohort study.
SETTING: Tertiary pediatric ICUs. PATIENTS: All patients admitted to the pediatric ICU who required ECMO for respiratory failure from 1995 to 2000.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Medical records for 93 patients representing 95 ECMO runs for treatment of respiratory failure were reviewed. Of these, 63 patients (66%) received intermittent prone positioning. Demographic data and clinical information were recorded. The median age was 12 months, and the median weight was 9.8 kg. There were 962 position changes. Complications surveyed for included bleeding from appliance insertion sites, appliance dislodgment, unplanned extubation, cutaneous pressure ulceration, corneal abrasion, and extreme hemodynamic instability. These complications were noted as to whether they were present prior to the initiation of prone positioning or whether they developed after prone positioning began. Twenty-four percent of patients had bleeding from cannulation sites prior to prone positioning, and 18% of patients had bleeding begin after prone positioning was initiated. Two patients had chest tubes dislodge after prone positioning began, but neither patient had bleeding occur or required reinsertion of the chest tube. There were no unplanned extubations, appliance displacements, development of cutaneous pressure ulcerations, or corneal abrasions associated with prone-positioning maneuvers. No patient had ECMO support removed secondary to the surveyed complications. Eighty-two percent of children who received prone positioning during ECMO for treatment of respiratory failure survived to hospital discharge.
CONCLUSION: We found that prone positioning may be used in pediatric ECMO patients without increasing the risk of complications. A multi-institutional, prospective, randomized, controlled study would better evaluate the efficacy of this practice and whether it is associated with a shorter length of ECMO or shorter post-ECMO ventilation and outcome.

Entities:  

Mesh:

Year:  2003        PMID: 12740278     DOI: 10.1378/chest.123.5.1589

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Prone positioning use to hasten veno-venous ECMO weaning in ARDS.

Authors:  Antoine Kimmoun; Philippe Guerci; Céline Bridey; Nicolas Ducrocq; Fabrice Vanhuyse; Bruno Levy
Journal:  Intensive Care Med       Date:  2013-07-09       Impact factor: 17.440

Review 2.  Extracorporeal membrane oxygenation for pediatric respiratory failure: History, development and current status.

Authors:  Anna Maslach-Hubbard; Susan L Bratton
Journal:  World J Crit Care Med       Date:  2013-11-04

3.  Effect of prone positioning on cannula function and impaired oxygenation during extracorporeal circulation.

Authors:  Yoshiki Masuda; Hiroomi Tatsumi; Hitoshi Imaizumi; Kyoko Gotoh; Shinichiro Yoshida; Shinya Chihara; Kanako Takahashi; Michiaki Yamakage
Journal:  J Artif Organs       Date:  2013-11-17       Impact factor: 1.731

Review 4.  Extracorporeal life support for patients with acute respiratory distress syndrome: report of a Consensus Conference.

Authors:  Christian Richard; Laurent Argaud; Alice Blet; Thierry Boulain; Laetitia Contentin; Agnès Dechartres; Jean-Marc Dejode; Laurence Donetti; Muriel Fartoukh; Dominique Fletcher; Khaldoun Kuteifan; Sigismond Lasocki; Jean-Michel Liet; Anne-Claire Lukaszewicz; Hervé Mal; Eric Maury; David Osman; Hervé Outin; Jean-Christophe Richard; Francis Schneider; Fabienne Tamion
Journal:  Ann Intensive Care       Date:  2014-05-24       Impact factor: 6.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.